Mirae Asset Global Investments Co., Ltd. Voyager Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,624 shares of VYGR stock, worth $10,150. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,624Holding current value
$10,150% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding VYGR
# of Institutions
128Shares Held
36.7MCall Options Held
48KPut Options Held
36.2K-
Black Rock Inc. New York, NY5.31MShares$33.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$32.5 Million0.54% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$24.5 Million1.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.04MShares$19 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.29MShares$14.3 Million0.09% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $242M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...